Profile
Charles S.
Grass worked as a Senior Director-Finance at Agile Therapeutics, Inc. in 2020 and as a Chief Accounting Officer at Bellicum Pharmaceuticals, Inc.
Former positions of Charles S. Grass
| Companies | Position | End |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2024-02-22 |
| AGILE THERAPEUTICS, INC. | Director of Finance/CFO | 2020-05-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Charles S. Grass
